Search

Your search keyword '"Honce JM"' showing total 2 results
Start Over Author "Honce JM" Topic antineoplastic agents
2 results on '"Honce JM"'

1. Central Nervous System Response to Selpercartinib in Patient With RET-rearranged Non-small Cell Lung Cancer After Developing Leptomeningeal Disease on Pralsetinib.

Author

Tsui DCC, Kavanagh BD, Honce JM, Rossi C, Patil T, and Camidge DR

Subjects
Female, Humans, Meningeal Neoplasms, Middle Aged, Antineoplastic Agents pharmacology, Carcinoma, Non-Small-Cell Lung drug therapy, Central Nervous System drug effects, Central Nervous System physiopathology, Lung Neoplasms drug therapy, Proto-Oncogene Proteins c-ret, Pyrazoles pharmacology, Pyrazoles therapeutic use, Pyridines pharmacology, Pyridines therapeutic use, Pyrimidines pharmacology, Pyrimidines therapeutic use
Published
2022
Full Text
View/download PDF

2. Lorlatinib Salvages CNS Relapse in an ALK-Positive Non-Small-Cell Lung Cancer Patient Previously Treated With Crizotinib and High-Dose Brigatinib.

Author

Sakamoto MR, Honce JM, Lindquist DL, and Camidge DR

Subjects
Adult, Aminopyridines, Anaplastic Lymphoma Kinase antagonists & inhibitors, Central Nervous System drug effects, Drug Approval, Humans, Lactams, Male, Neoplasm Metastasis, Pyrazoles, Recurrence, Treatment Outcome, Antineoplastic Agents therapeutic use, Carcinoma, Non-Small-Cell Lung drug therapy, Central Nervous System pathology, Crizotinib therapeutic use, Lactams, Macrocyclic therapeutic use, Lung Neoplasms drug therapy, Organophosphorus Compounds therapeutic use, Pyrimidines therapeutic use
Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results